The Reserve Bank of India has set the limit for Ways and Means Advances (WMA) for the Central Government for the first half of the financial year 2022-23 (April 2022 to September 2022) at Rs. 1,50,000 crore.
Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.